These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8494096)

  • 41. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cadmium-induced changes in lipid peroxidation, blood hematology, biochemical parameters and semen quality of male rats: protective role of vitamin E and beta-carotene.
    El-Demerdash FM; Yousef MI; Kedwany FS; Baghdadi HH
    Food Chem Toxicol; 2004 Oct; 42(10):1563-71. PubMed ID: 15304303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Free radical oxidation during experimental pneumonia].
    Farkhutdinov UR; Farkhutdinov RR
    Biull Eksp Biol Med; 2000 Mar; 129(3):260-4. PubMed ID: 10776559
    [No Abstract]   [Full Text] [Related]  

  • 44. Tardive dyskinesia: eliminated, forgotten, or overshadowed?
    Remington G
    Curr Opin Psychiatry; 2007 Mar; 20(2):131-7. PubMed ID: 17278910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Free radical oxidation of lipids of human serum depending on its vitamin E level].
    Kuz'menko AI; Klimenko EP; Donchenko GV
    Biull Eksp Biol Med; 1997 Sep; 124(9):298-301. PubMed ID: 9445611
    [No Abstract]   [Full Text] [Related]  

  • 46. The management of tardive dyskinesia.
    Drug Ther Bull; 1986 Apr; 24(7):27-8. PubMed ID: 3769787
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of propranolol in treating tardive dyskinesia.
    Einarson TR
    Can Med Assoc J; 1981 May; 124(10):1260, 1262. PubMed ID: 7237311
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of choline and lecithin in the treatment of tardive dyskinesia.
    Zeisel SH; Gelenberg AJ; Growdon JH; Wurtman RJ
    Adv Biochem Psychopharmacol; 1980; 24():463-70. PubMed ID: 6996444
    [No Abstract]   [Full Text] [Related]  

  • 49. Clonazepam and tardive dyskinesia.
    Barnes TR; Kidger T
    Am J Psychiatry; 1981 Aug; 138(8):1127-8. PubMed ID: 7258398
    [No Abstract]   [Full Text] [Related]  

  • 50. [Tiapride (Tiapridal) in tardive dyskinesia: another Beelzebub?].
    Nolen WA; Moleman P; Loonen AJ
    Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2022-3. PubMed ID: 7177212
    [No Abstract]   [Full Text] [Related]  

  • 51. Should Sisyphus have taken melatonin?
    Glazer WM; Woods SW; Goff D
    Arch Gen Psychiatry; 2001 Nov; 58(11):1054-5. PubMed ID: 11695952
    [No Abstract]   [Full Text] [Related]  

  • 52. Vitamin E and coronary heart disease.
    Morris SD; Yellon DM
    Lancet; 1996 Jun; 347(9016):1690; author reply 1691. PubMed ID: 8642975
    [No Abstract]   [Full Text] [Related]  

  • 53. Progress in psychiatry.
    Lynch T; Burke RE; Fahn S
    N Engl J Med; 1994 Jan; 330(4):285-6. PubMed ID: 8272093
    [No Abstract]   [Full Text] [Related]  

  • 54. Tardive Dyskinesia, Lipid Peroxidation and Vitamin E: Peet M1, Laugharne J1, Rangarajan N1, Reynolds GP2, Watson REB2, Cutts AJ2. Academic Department of Psychiatry1, Northern General Hospital, Sheffield S5 7AU; Department of Biomedical Science2, University of Sheffield, Sheffield S10 2TN.
    J Psychopharmacol; 1992 Jan; 6(1):104. PubMed ID: 22291256
    [No Abstract]   [Full Text] [Related]  

  • 55. Vitamin E and dapsone-induced hemolysis.
    Smith KC
    CMAJ; 1994 Jan; 150(2):128. PubMed ID: 8287332
    [No Abstract]   [Full Text] [Related]  

  • 56. More on the use of manganese in dyskinesia.
    Norris JP; Sams RE
    Am J Psychiatry; 1977 Dec; 134(12):1448. PubMed ID: 920860
    [No Abstract]   [Full Text] [Related]  

  • 57. Antioxidants as potential therapeutics for neuropsychiatric disorders.
    Pandya CD; Howell KR; Pillai A
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():214-23. PubMed ID: 23123357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.
    Yao JK; Reddy RD; van Kammen DP
    CNS Drugs; 2001; 15(4):287-310. PubMed ID: 11463134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin E treatment of tardive dyskinesia.
    Corrigan FM; Van Rhijn AG; Mackay AV; Skinner ER; Horrobin DF
    Am J Psychiatry; 1993 Jun; 150(6):991-2; author reply 992-3. PubMed ID: 8494096
    [No Abstract]   [Full Text] [Related]  

  • 60. Vitamin E treatment of tardive dyskinesia.
    Holmes VF; D'Alli R; Schweickert L; White R; Brown T; Doraiswamy M; Garcia M
    Am J Psychiatry; 1993 Jun; 150(6):991; author reply 992-3. PubMed ID: 8494095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.